# Platelet Aggregation Inhibitors and Anticoagulants Delay Surgery for Hip Fractures
## 3 Results
There were no differences in transfusions except for fresh frozen plasma, which was administered significantly more in patients on platelet aggregation inhibitors and anticoagulant medication (\(p<0.0001\)) (Table 3). \begin{table}
\begin{tabular}{c c c c} \hline \hline  & **Antithrombotic (n = 106)** & **No Medication (n = 245)** & \(p\) \\ \hline Age, years (mean \(\pm\) SD) & 78.45 \(\pm\) 8.63 & 77.14 \(\pm\) 9.37 & NS \\ Gender & & & \\ Male, n (\%) & 32 (30.19) & 69 (28.16) & NS \\ Female, n (\%) & 74 (69.81) & 176 (71.84) & NS \\ Hb at admittance, g/dL & 12.22 \(\pm\) 1.92 & 11.77 \(\pm\) 1.80 & 0.03 \\ Charlson index, points (median [IQR]) & 5 [4; 5] & 4 [3; 5] & \textless{}0.0001 \\ Charlson index survival (median [IQR]) & 21 [21; 22; 23; 24; 25; 26; 27; 28; 29; 30; 31; 32; 33; 34; 35; 36; 37; 38; 39; 40; 41; 42; 43; 44; 45; 46; 47; 48; 49; 50; 51; 52 \begin{table}
\begin{tabular}{c c c c c c c c} \hline \hline  & **Group 1 (n = 90)** & **Acetylicylic Acid (n = 40)** & **Clopidogrel (n = 19)** & **Aceonocumarin (n = 18)** & **DOACs (n = 13)** & **Group 2 (n = 222)** & \(p^{*}\) \\ \hline Agx, years (mon a SD) & 78.41 \(\pm\) 8.86 & 78.54 \(\pm\) 8.79 & 76.67 \(\pm\) 8.96 & 79.11 \(\pm\) 9.45 & 79 \(\pm\) 8.95 & 78.86 \(\pm\) 9.46 & NS (0.18) \\ Gender & & & & & & \\ Male, n (5) & 27 (30) & 13 (58.95) & 2 (13.33) & 8 (44.44) & 4 (00.77) & 61 (27.48) & NS \\ Female, n (5) & 63 (70) & 31 (70.45) & 13 (08.67) & 10 (55.56) & 9 (69.22) & 16 (25.25) & \\ Charlton Index, points (median [IQR]) & 5 [4–5] & 5 [4–5] & 5 [4–5] & 5 [4–5] & 5 [4–5] & 5 [4–5] & 4 (3–5] & \(<\)0.0001 \\ Charlton index survival, median [IQR] & 21 [2–53] & 21 (11.5–53) & 21 [2–53] & 21 [2–53] & 21 [2–53] & 21 [2–53] & 53 [2–17] & \(<\)0.0001 \\ Type of fracture & & & & & & & \\ Intracapapular, neck, n (5) & 31 (44.44) & 16 (83.63) & 3 (20) & 5 (27.98) & 7 (53.85) & 6 (27.03) & NS \\ Extracapcapcap, fracture location, n (5) & 9 (65.56) & 28 (63.64) & 12 (80) & 13 (22.22) & 6 (64.15) & 16 (27.95) & \\ Time to surgery, days (median [IQR]) & 4 [3–6] & 3 [1–4] & 6 (52.75) & 4 [5–7] & 5 [4–25] & 21 [1–4] & \(<\)0.0001 \\  & 4 [3–6] & 3 [2–4] & 10 (73.75) & 5 (4–5) & 7 [5–25] & 21 [1–4] & \(<\)0.0001 \\ Intracapular, neck & (n = 31) & (n = 16) & (n = 3) & (n = 5) & (n = 7) & (n = 60) & \\ Extracapular, hexatactic region & 4 [3–5] & 3 [1–5] & 6 (5–7) & 4 [3–7] & 4 [4–4] & 21 [0–9] & \(<\)0.0001 \\  & (n = 59) & (n = 28) & (n = 12) & (n = 13) & (n = 6) & (n = 182) & \\ Length of stay, days & 17 [13–2] & 14.5 [10–18] & 19 [16.25–21] & 17 [15–19] & 19 [14.75–26.25] & 13 [10–16] & \(<\)0.0001 \\ \hline \hline \end{tabular}
\end{table} 
Table 2: Surgically treated patients. \begin{table}
\begin{tabular}{c c c c c c c} \hline \hline  & **Group 1 (n = 90)** & **Acetylicylic Acid (n = 40)** & **Clopidogrel (n = 19)** & **Aceonocumarin (n = 18)** & **DOACs (n = 13)** & **Group 2 (n = 222)** & \(p^{*}\) \\ \hline Hb at admittance, g/dL & 12.17 \(\pm\) 1.85 & 12.31 \(\pm\) 1.69 & 12.12 \(\pm\) 1.89 & 11.85 \(\pm\) 2.01 & 12.14 \(\pm\) 2.23 & 11.75 \(\pm\) 1.78 & NS (0.06) \\ Hb postp, g/dL & 10.45 \(\pm\) 1.6 & 10.61 \(\pm\) 1.83 & 10.57 \(\pm\) 1.36 & 10.43 \(\pm\) 1.23 & 9.83 \(\pm\) 1.48 & 10.9 \(\pm\) 1.31 & NS (0.08) \\ Packed red blood cells & (n = 40) & (n = 14) & (n = 17) & (n = 13) & (n = 260) & \\ \hline n (5) & 34 (307.78) & 14 (31.82) & 7 (46.67) & 9 (50) & 4 (00.77) & 75 (33.78) & NS \\ units (median IQR) & & 1.5 [1–2] & 1 [1–1] & 2 [1–3] & 1 [1–1] & 2 [1–2] & 0.01 \\ Fresh frozen plasma & & & & & & \\ n (5) & 15 (16.67) & 3 (6.82) & 1 (6.67) & 4 (22.22) & 7 (53.86) & 17 (7.65) & \(<\)0.0001 \\ units (median IQR) & & 2 [2–2] & 1 [1–1] & 2 [1–5–5] & 2 [1.25–275] & 2 [1–4] & NS \\ Platelet mass & & & & & & \\ n (5) & 3 (33) & 1 (2.27) & 0 & 1 (5.56) & 1 (7.69) & 5 (2.25) & NS \\ units (median IQR) & & 1 & – & 8 & 2 & 2 [1.75–5.575] & NS \\ \hline \hline \end{tabular}
\end{table} 
Table 3: Transfusions.